DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹611 Cr | ₹557 Cr | ₹437 Cr | ₹364 Cr | ₹295 Cr |
What is the latest Total Non-Current Liabilities ratio of DIVIS LABORATORIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹611 Cr |
Mar2023 | ₹557 Cr |
Mar2022 | ₹437 Cr |
Mar2021 | ₹364 Cr |
Mar2020 | ₹295 Cr |
How is Total Non-Current Liabilities of DIVIS LABORATORIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹611 Cr | 9.69 | |
Mar2023 | ₹557 Cr | 27.60 | |
Mar2022 | ₹437 Cr | 19.94 | |
Mar2021 | ₹364 Cr | 23.55 | |
Mar2020 | ₹295 Cr | - |
Compare Total Non-Current Liabilities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹149,232.2 Cr | -3.9% | -7.9% | 51% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,692.0 Cr | -5.3% | -7.8% | 24.1% | Stock Analytics | |
CIPLA | ₹115,000.0 Cr | -1.9% | -6.9% | 3.6% | Stock Analytics | |
MANKIND PHARMA | ₹102,232.0 Cr | -5.9% | -14% | 21% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,616.4 Cr | -8.3% | -14.9% | 0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹93,841.4 Cr | -5.7% | -4% | 23.6% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -3.9% |
-7.9% |
51% |
SENSEX | 0.2% |
-2.2% |
7.7% |
You may also like the below Video Courses